pharmaphorum
SEPTEMBER 30, 2021
Merck said the two drugs will “complement and strengthen” its cardiovascular pipeline – which has been somewhat eclipsed by its vaccines and oncology businesses in recent years. Sales of Reblozyl were $240 million in the first half of the year, as booked by BMS, with Acceleron claiming a $48 million share of the total.
pharmaphorum
MARCH 9, 2021
Nearly 70% of HCPs are now digital natives, with no interest in going back to pre-COVID sales engagement methods. To thrive in this environment, pharma needs to move from ad-hoc and reactionary digital transformation to long-term ‘digital excellence’, says Veeva’s Sebastien Noel. Market pressures. Achieving digital excellence.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
FEBRUARY 23, 2023
Spanish pharma company Ferrer and Swiss biotech Asceneuron have signed a licensing agreement giving Ferrer the rights to ASN90 in progressive supranuclear palsy (PSP), an orphan, tau-related disease with a high unmet medical need. Asceneuron is also eligible to receive tiered double-digit royalties on worldwide net sales of ASN90.
pharmaphorum
JANUARY 26, 2021
Life sciences companies need to rethink their customer engagement paradigms in light of changing customer preferences. Pharma companies will need to continually rethink what works and not be afraid to experiment with solutions they’ve never tried before. As such, reps will need to be reskilled.
pharmaphorum
OCTOBER 3, 2022
Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the entertainment industry and prepare for the Metaverse to enhance content engagement. Pharma companies’ customer communication methods require reimagining as technology progresses.
pharmaphorum
APRIL 25, 2022
Aaron Gani, founder and CEO of BehaVR, and Krys Zaluski, director of business development, digital health at Sumitomo Dainippon Pharma, discuss their groundbreaking partnership to develop and commercialise digital therapeutics (DTx) products. . They also understand how to do clinical trial design,” Gani states.
Delveinsight
SEPTEMBER 8, 2021
In the very beginning, it becomes a necessity for a Business Consultant to have appropriate knowledge about their client’s business. So discovering and learning about the company as a whole becomes essential.
Expert insights. Personalized for you.
117 
Let's personalize your content